A Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)

Trial Profile

A Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Muscle-derived autologous stem cell therapy Bioheart (Primary)
  • Indications Heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms MARVEL
  • Sponsors U.S. Stem Cell
  • Most Recent Events

    • 20 Jul 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2019.
    • 26 Jan 2015 According to the ClinicalTrials.gov record, planned changed from 1 Feb 2012 to 1 Feb 2017.
    • 26 Jan 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Feb 2014 to 1 Feb 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top